Showing results (291-300 of 782) with videos related to
Sort By:
Pageof 79
Cardiology in Review|March 24, 2021
Cardiovascular and Cerebrovascular Complications With COVID-19Arielle Greenberg, Gayatri Pemmasani, Srikanth Yandrapalli, et al.Cardiology in Review|April 17, 2010
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosisCourtney B Sherman, Stephen J Peterson, William H FrishmanCardiology in Review|June 19, 2007
Cardiovascular drug therapy in the elderlyWilbert S Aronow, William H Frishman, Angela Cheng-LaiCardiology in Review|August 11, 2020
Effect of Bariatric Surgery on Cardiovascular Function and Heart Failure OutcomesBeth Hillary Mottel, David Allen Lindsay, William H FrishmanHeart Disease (Hagerstown, Md.)|May 25, 2002
Innovative drug treatments for viral and autoimmune myocarditisWilliam H Frishman, Miechelle O'Brien, Nauman Naseer, et al.Heart Disease (Hagerstown, Md.)|January 29, 2003
Anemia and hypocholesterolemiaBulent Atac, Driola Brahaj, William H Frishman, et al.Heart Disease (Hagerstown, Md.)|April 27, 2002
Congestive heart failure and continuous positive airway pressure therapy: support of a new modality for improving the prognosis and survival of patients with advanced congestive heart failureGary T Midelton, William H Frishman, Stanley S PassoCurrent Problems in Cardiology|February 5, 2008
Myocardial regeneration and stem cell repairAnnarosa Leri, Jan Kajstura, Piero Anversa, et al.Cardiology in Review|August 28, 2024
Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic CardiomyopathyJared M Feldman, William H Frishman, Wilbert S AronowCardiology in Review|January 3, 2024
Sacubitril-Valsartan (LCZ696) in the Treatment of Systemic Hypertension: An Updated Review of Neprilysin Inhibition Combined with Angiotensin II Receptor BlockadeMiriam E Katz, William H Frishman, Wilbert S AronowPageof 79